期刊文献+

左沙丁胺醇盐酸盐的制备及其S-对映体的外消旋化 被引量:1

Study on Preparation of Levalbuterol Hydrochloride and Racemization of S-Enantiomer
在线阅读 下载PDF
导出
摘要 目的制备左沙丁胺醇盐酸盐,并对拆分后得到的S一沙丁胺醇进行外消旋化。方法光学拆分剂L-酪氨酸与外消旋沙丁胺醇形成非映异构体盐,利用两者在甲醇-乙酸乙酯(1:2)溶剂体系中溶解度的差异,完成两者的分离。去除L-酪氨酸后,分别得到R-和S-沙丁胺醇。左沙丁胺醇经过酸化,得到左沙丁胺醇盐酸盐。同时,在1mol·L^-1硫酸溶液,80-90℃条件下,S-沙丁胺醇被外消旋化。结果拆分法得到左沙丁胺醇盐酸盐光学纯度99.1%(ennatiomer excess,EE),总收率为38,7%。S-沙丁胺醇经过外消旋化反应由85.5%EE转变为10.2%EE,收率83.0%。结论通过消旋化作用,S-沙丁胺醇产物可以重新回收利用,能大幅度提高左沙丁胺醇的收率,降低成本,该方法具有广阔的工业化前景。 OBJECTIVE To prepare levalbuterol hydrochloride and make S-salbuterol racemized after the resolution. METHODS The racemic salbuterol and optical resolving agent L-tyrosine were interacted to the formation of diastereomer salt. In the methanol-ethyl acetate ( 1: 2) solvent system, two diastereomer salts were separated by their solubility differences, and after the re- move of L-tyrosine, R-and S-salbuterol were obtained respectively. After acidification, levalbuterol chloride was prepared. Meanwhile, S-salbuterol was racemized at 80 - 90 ℃ in 1 mol · L^- 1 sulfuric acid solution. RESULTS Levalbuterol chloride was 99. 1% EE. And the total yield was 38.7%. S-salbuterol changed from the 85. 5% EE to 10. 2% EE after racemic reaction and the yield was 83.0%. CONCLUSION By the racemization, S-salbuterol can be recycled substantially, increasing the yield of levalbuterol and lowering costs. This method has cheerful prospects for industrialization.
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第21期1668-1669,共2页 Chinese Pharmaceutical Journal
关键词 左沙丁胺醇 拆分 外消旋化 制备 levalbuterol resolution racemization preparation
作者简介 王凯,男,讲师 通讯作者:巨修练,男,教授,博士生导师Tel:(027)62108255 E—mail:xiulianju2008@yahoo.com.cn
  • 相关文献

参考文献9

  • 1HAROLD S, NELSON M D. Clinical experience with levalbuterol [ J]. J Allergy Clin lmmunol, 1999, 104 (2):77-84.
  • 2何炜,张邦乐,李晓晔,刘鹏,孙晓莉,张生勇.左旋沙丁胺醇盐酸盐的合成[J].中国药物化学杂志,2006,16(4):222-225. 被引量:9
  • 3肖元晶,杨守宁,石炜,杨琍苹.α-亚胺酮的不对称转移氢化合成(R)-沙丁胺醇[J].有机化学,2006,26(8):1103-1105. 被引量:7
  • 4FERRAYOLI C G, PALACIO M A, BRESINA M F, et al. Resolution of racemic albuterol via diastereomeric salts formation with di-ptoluoyl-D-tartaric acid [ J]. Enantiomer, 2000, 5 (3-4):289-291.
  • 5CAIRA M R, HUNTER R, NASSIMBENI L R, et al. Resolution of albuterol acetonide [ J ]. Tetrahedron : Asymmetry, 1999, 10 : 2175-2189.
  • 6ALEJANDRA H, CARLOS F, MARCELA P, et al. Validation of a chiral HPLC assay for (R) -salbutamol sulfate [ J]. J Pharm Biota Anal, 2004, 34 ( 1 ) :45-51.
  • 7STEVENS A, HUNTER R, NASSIMBENI L, et al. Process for the production of optically enriched ( R)-or ( S)-albuterol: WO, 9942460 [P]. 2002-04 -02.
  • 8陈扬,刘相奎,张小敏,袁哲东.盐酸左旋沙丁胺醇的制备[J].中国医药工业杂志,2006,37(6):376-378. 被引量:3
  • 9BUCKINGHAM J. Dictionary of Organic Compound[ M]. Vol. 5. 5th ed, New York:Chapman and Hall, 1982:4946.

二级参考文献42

  • 1刘春涛,孙翊道.呼吸系统疾病的回顾与展望[J].四川医学,2004,25(12):1358-1361. 被引量:3
  • 2Boulton DW,Fawcett JP.Pharmacokinetics and pharmacodynamics of single oral dose of albuterol and its enantionmers in humans[J].Clin Pharmacol Ther,1997,62:138-144.
  • 3邓金根 钟庆林 廖建 等.R—沙丁胺醇酒石酸盐的制备方法[P].CN:1382685,2002—12—04[J].CA,2004,140:3570-3570.
  • 4Stevens A,Hunter R,Nassimbeni L,et al.Process for the production of optically enriched (R)-or (S)-albuterol[P].WO:9942460,2002-04-02.(CA 1999,131:784952)
  • 5Gao Y,Zepp CM.Enantioselective preparation of optically pure albuterol[P].US:5545745,1996-08-13.(CA 1996,125:167556)
  • 6Gao Y,Zepp CM.Enantioselective preparation of optically pure albuterol[P].WO:9532178,1995-11-30.(CA 1995,124:232035)
  • 7Bergmeiyer, S. C. Tetrahedron 2000, 56, 2561.
  • 8Main, B. Ct; Tucker, H. In Medicinal Chemistry, 2nd ed.,Eds.: Genellin, C. R.; Roberts, S. M., Academic, New York,1993, p. 187.
  • 9Nials, A. T.; Coleman, R. A.; Johnson, M.; Vardey, C. J.Am. Rev. Resp. Dis. 1994, 149, A481.
  • 10Millership, J. S.; Fitzpatrick, A. Chirality 1993, 5, 573.

共引文献13

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部